{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:48:20Z","timestamp":1794970100488,"version":"4.9.1"},"reference-count":95,"publisher":"American Chemical Society (ACS)","issue":"14","license":[{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2023,7,27]]},"DOI":"10.1021\/acs.jmedchem.3c00550","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T12:07:33Z","timestamp":1688558853000},"page":"9297-9312","source":"Crossref","is-referenced-by-count":108,"title":["Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes"],"prefix":"10.1021","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8750-679X","authenticated-orcid":true,"given":"Ingo V.","family":"Hartung","sequence":"first","affiliation":[{"name":"Medicinal Chemistry, Global Research & Development, Merck Healthcare KGaA, 64293 Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0806-6106","authenticated-orcid":true,"given":"Joachim","family":"Rudolph","sequence":"additional","affiliation":[{"name":"Discovery Chemistry, Genentech, South San Francisco, California 94080, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8832-7187","authenticated-orcid":true,"given":"Mary M.","family":"Mader","sequence":"additional","affiliation":[{"name":"Molecular Innovation, Indiana Biosciences Research Institute, Indianapolis, Indiana 64202, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5386-7132","authenticated-orcid":true,"given":"Monique P. C.","family":"Mulder","sequence":"additional","affiliation":[{"name":"Department of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1659-3034","authenticated-orcid":true,"given":"Paul","family":"Workman","sequence":"additional","affiliation":[{"name":"Centre for Cancer Drug Discovery, The Institute of Cancer Research, London, Sutton SM2 5NG, United Kingdom"},{"name":"Chemical Probes Portal,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1039\/D2MD00291D"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3439-c1"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1867"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1039\/D1MD00228G"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2010.05.013"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.07.010"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1197"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00542-z"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1038\/nature18002"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.9b02822"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00371-6"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2021.04.009"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-0438-0"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1039\/D2CS00478J"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2019.09.012"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20160762"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac909"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2004.11.007"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.crchbi.2022.100040"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.419"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1313733111"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-018-0061-5"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115865"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.32"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01438"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b02052"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01180"},{"key":"ref29\/cit29","doi-asserted-by":"crossref","unstructured":"Nichols, R. J. RMC-6291, a Next-Generation Tri-Complex KRasG12C(ON) Inhibitor, Outperforms KRasG12C(OFF) Inhibitors in Preclinical Models of KRasG12C Cancers, 2022. https:\/\/www.revmed.com\/media\/rmc-6291-next-generation-tri-complex-kras-g12con-inhibitor-outperforms-kras-g12coff (accessed 2023-02-06).","DOI":"10.1158\/1538-7445.AM2022-3595"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-ND11"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01120"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1021\/jm500973a"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.0c00104"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.7b00185"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201611907"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1039\/D1CS00231G"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.07.001"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2208457119"},{"key":"ref39\/cit39","unstructured":"Lanman, B. A. Inhibiting KRas: Strategies, Structures, and Lessons Learned in the Invention of Sotorasib, 2023. https:\/\/www.gdch.de\/netzwerk-strukturen\/fachstrukturen\/medizinische-chemie\/veranstaltungen\/medchemcases.html (accessed 2023-02-15)."},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1021\/jm501412a"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-022-01098-0"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.1c13568"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2019.09.012"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113481"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1694-1"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1021\/jm400822z"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00891"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01308"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2016.10.008"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2166"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01019"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1038\/nature12796"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-020-0501-5"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1039\/D2SC04820E"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.0c04527"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.0c07726"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2020.09.001"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.2c05377"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-022-01065-9"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202203878"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2018.12.001"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2020-0073"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02158-2"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2019.12.006"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28507-1"},{"key":"ref66\/cit66","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.R120.002190"},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27818-z"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2017.09.010"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2015.05.009"},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.5b00216"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2021.04.007"},{"key":"ref72\/cit72","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.18.468552"},{"key":"ref73\/cit73","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/9783527836208.ch8","volume-title":"Inducing Targeted Protein Degradation","author":"Zhang X.","year":"2023"},{"key":"ref74\/cit74","unstructured":"Thede, K.; Buchgraber, P.; Siemeister, G.; Steigemann, P.; Wegner, A. M.; Boemer, U.; Barak, N.; Lienau, P. Pyrazolotriazines for Treatment of Hyperproliferative Diseases and Their Preparation. WO2021116718."},{"key":"ref75\/cit75","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0668-z"},{"key":"ref76\/cit76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1814446115"},{"key":"ref77\/cit77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95354-3"},{"key":"ref78\/cit78","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.7b00903"},{"key":"ref79\/cit79","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.03.012"},{"key":"ref80\/cit80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33430-6"},{"key":"ref81\/cit81","unstructured":"Boehringer Ingelheim. SMARCA2 PROTAC ACBI2. https:\/\/opnme.com\/molecules\/smarca2-acbi2 (accessed 2023-02-17)."},{"key":"ref82\/cit82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34562-5"},{"key":"ref83\/cit83","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01313"},{"key":"ref84\/cit84","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2023.02.005"},{"key":"ref85\/cit85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28907-3"},{"key":"ref86\/cit86","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2374-x"},{"key":"ref87\/cit87","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.08.081"},{"key":"ref88\/cit88","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2925-1"},{"key":"ref89\/cit89","unstructured":"Snyder, L. B. Discovery of ARV-110, a First in Class Androgen Receptor Degrading PROTAC for the Treatment of Men with Metastatic Castration Resistant Prostate Cancer, 2021. https:\/\/ir.arvinas.com\/static-files\/99279395-e91e-44d1-8ad9-88db2024c1fa (accessed 2022-02-07)."},{"key":"ref90\/cit90","unstructured":"Snyder, L. B. The Discovery of ARV-471, an Orally Bioavailable Estrogen Receptor Degrading PROTAC for the Treatment of Patients with Breast Cancer, 2021. https:\/\/ir.arvinas.com\/static-files\/7a4db470-3d7f-4d4b-98a4-481b8c573169 (accessed 2022-02-07)."},{"key":"ref91\/cit91","unstructured":"Daniels, D. L. Progressing Degraders Towards and Through the Clinic, 2022. https:\/\/foghorntx.com\/wp-content\/uploads\/2022\/10\/HansonWade-5th-Annual-TPD-Summit-October-2022.pdf (accessed 2023-02-17)."},{"key":"ref92\/cit92","unstructured":"Jackson, K. L. The Discovery and Characterization of CFT8634: A Potent and Selective Degrader of BRD9 for the Treatment of SMARCB1-Perturbed Cancers, 2022. https:\/\/ir.c4therapeutics.com\/static-files\/afbcfbff-e253-4964-b9de-3fb564fb861b (accessed 2023-02-17)."},{"key":"ref93\/cit93","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00146"},{"key":"ref94\/cit94","unstructured":"Boehringer Ingelheim. BCL6 degrader BI-3802. https:\/\/www.opnme.com\/molecules\/bcl6-bi-3802 (accessed 2023-02-17)."},{"key":"ref95\/cit95","unstructured":"Hou, T. The PROTAC Database, PROTAC-DB. http:\/\/cadd.zju.edu.cn\/protacdb\/ (accessed 2023-02-17)."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.3c00550","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.3c00550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T08:23:11Z","timestamp":1690446191000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.3c00550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":95,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,7,27]]}},"alternative-id":["10.1021\/acs.jmedchem.3c00550"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00550","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]}}}